Cargando…

Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn’s Disease

BACKGROUND: Cutaneous Crohn’s Disease is a notoriously difficult condition to treat and causes significant morbidity, impacting heavily on quality of life. This is the first study in adults examining the effect of topical tacrolimus on the different cutaneous manifestations of Crohn’s Disease. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rice, Shantini A, Woo, Pick N, El-Omar, Emad, Keenan, Ronald A, Ormerod, Anthony D
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607997/ https://www.ncbi.nlm.nih.gov/pubmed/23331739 http://dx.doi.org/10.1186/1756-0500-6-19

Ejemplares similares

The Use of Topical Tacrolimus 0.1% Skin Ointment for Anterior Segment Conditions: A Case Series
por: Abeysiri, Poorna, et al.
Publicado: (2010)

Maintenance Therapy of Facial Seborrheic Dermatitis with 0.1% Tacrolimus Ointment
por: Kim, Hye One, et al.
Publicado: (2015)

EFFECT OF 0.1% TACROLIMUS OINTMENT IN LOCALIZED VITILIGO: AN OPEN UNCONTROLLED TRIAL
por: Bhuvana, K, et al.
Publicado: (2011)

Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis
por: Saha, Bhawesh Chandra, et al.
Publicado: (2023)

Comparison of topical clobetasol propionate 0.05% and topical tacrolimus 0.1% in the treatment of cutaneous lichen planus
por: Özkur, Ezgi, et al.
Publicado: (2020)

Efficacy of topical application of 0.03% tacrolimus eye ointment in the management of allergic conjunctivitis
por: Hazarika, Ajit Kumar, et al.
Publicado: (2015)

Successful Treatment of Recalcitrant Granuloma Gluteale Infantum with Topical Tacrolimus 0.03% Ointment
por: Leung, Alexander K. C., et al.
Publicado: (2021)

Treatment of balanitis of Zoon's with tacrolimus 0.03% ointment
por: Chander, Ram, et al.
Publicado: (2009)

Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East
por: Fiorentini, Sandra Flavia, et al.
Publicado: (2019)

Long-term results of topical 0.02% tacrolimus ointment for refractory ocular surface inflammation in pediatric patients
por: Koh, Kyungmin, et al.
Publicado: (2021)

Double-Blind, Placebo-Controlled, Randomized Study Comparing 0.0003% Calcitriol with 0.1% Tacrolimus Ointments for the Treatment of Endemic Pityriasis Alba
por: Moreno-Cruz, Berenice, et al.
Publicado: (2012)

Abrupt Bullous Cutaneous Eruption After Application of Tacrolimus Ointment and Sun Exposure
por: Spigariolo, Cristina Beatrice, et al.
Publicado: (2023)

Tacrolimus ointment in the management of atopic dermatitis
por: Baldo, Antonello, et al.
Publicado: (2009)

Tacrolimus Ointment for Treatment of Vernal Keratoconjunctivitis
por: Al-Amri, Abdulrahman M., et al.
Publicado: (2016)

The Comparison of Efficacy of Adcortyl Ointment and Topical Tacrolimus in Treatment of Erosive Oral Lichen Planus
por: Azizi, Arash, et al.
Publicado: (2007)

Kaposi's Varicelliform Eruption During Long-term Treatment of Rosacea with 0.03% Tacrolimus Ointment
por: Chen, Qi-Quan, et al.
Publicado: (2015)

Therapeutic Effect of 0.03% Tacrolimus Ointment for Ocular Graft versus Host Disease and Vernal Keratoconjunctivitis
por: Ryu, Eun Hye, et al.
Publicado: (2012)

Tacrolimus 0.03% ointment for treatment of paediatric lichen sclerosus: a case series and literature review
por: Mazzilli, Sara, et al.
Publicado: (2018)

Acral Persistent Papular Mucinosis with Partial Response to Tacrolimus Ointment
por: Jun, Ji-Young, et al.
Publicado: (2016)

Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial
por: Dupuis-Girod, Sophie, et al.
Publicado: (2020)

Randomized Mechlorethamine/Chlormethine Induced Dermatitis Assessment Study (MIDAS) Establishes Benefit of Topical Triamcinolone 0.1% Ointment Cotreatment in Mycosis Fungoides
por: Alexander-Savino, Carolina V., et al.
Publicado: (2022)

Randomized Comparison of Topical Betamethasone Valerate Foam, Intralesional Triamcinolone Acetonide and Tacrolimus Ointment in Management of Localized Alopecia Areata
por: Kuldeep, CM, et al.
Publicado: (2011)

Evaluation of the use of tacrolimus ointment for the prevention of hypertrophic scars in experimental model
por: Menezes, Mariana Campos Souza, et al.
Publicado: (2019)

Ocular Hypertensive Response to Topical Dexamethasone Ointment in Children
por: Lee, Yoon Jung, et al.
Publicado: (2006)

308-nm excimer lamp with 0.03% tacrolimus ointment is safe and effective to treat children with non-segmental vitiligo
por: Li, Peishan, et al.
Publicado: (2022)

Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: Review on safety and benefits
por: Ohtsuki, Mamitaro, et al.
Publicado: (2018)

Tacrolimus ointment in the treatment of hormone-dependent dermatitis: A protocol of systematic review
por: Li, Mao, et al.
Publicado: (2020)

Progressing eczematous dermatitis in an infantile hemangioma with minimal or arrested growth treated with tacrolimus ointment
por: Alsaid, Raya Qais, et al.
Publicado: (2020)

Assessment of 5% Amlexanox, 0.1% Triamcinolone Acetonide and 0.03% Tacrolimus in the Management of Oral Lichen Planus
por: AlMutairi, Mohammed, et al.
Publicado: (2023)

Improving the Efficacy of EGFR Inhibitors by Topical Treatment of Cutaneous Squamous Cell Carcinoma with miR-634 Ointment
por: Inoue, Jun, et al.
Publicado: (2020)

Topical Management of Wound: A Narrative Review of Cadexomer Iodine Ointment Versus Povidone Iodine Ointment
por: Gupta, Shubham, et al.
Publicado: (2022)

Effect of the Recombinant Human Epidermal Growth Factor Ointment on Cutaneous Surgical Wounds Compared to Antibiotic Ointment
por: Ryu, Sook In, et al.
Publicado: (2021)

A randomized triple-blind clinical trial to compare the effectiveness of topical triamcinolone acetonate (0.1%), clobetasol propionate (0.05%), and tacrolimus orabase (0.03%) in the management of oral lichen planus
por: Sivaraman, Shivakumar, et al.
Publicado: (2016)

Combination of 0.05% Azelastine and 0.1% Tacrolimus Eye Drops in Children With Vernal Keratoconjunctivitis: A Prospective Study
por: Chen, Minjie, et al.
Publicado: (2021)

The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report
por: Becker, Jürgen C, et al.
Publicado: (2006)

Tacrolimus action pathways in an ointment base for hypertrophic scar prevention in a rabbit ear model()()
por: Menezes, Mariana Campos Souza, et al.
Publicado: (2021)

Aqueous penetration of topical tacrolimus
por: Shoughy, Samir S., et al.
Publicado: (2020)

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases
por: Yazu, Hiroyuki, et al.
Publicado: (2021)

Cheilitis Glandularis of Both Lips: Successful Treatment with a Combination of an Intralesional Steroid Injection and Tacrolimus Ointment
por: Sugaya, Norberto, et al.
Publicado: (2018)

Effectiveness of Topical Cyclosporin-A 0.1% Compared to Combined Topical Cyclosporin-A 0.1% with Topical Sodium Hyaluronate on Interleukin-6 Levels in the Tears of Patients with Dry Eye Disease
por: Priani, Desti, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_okb01he082k5sj0l799pss42di